Leuprolide

"Leuprolide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A potent synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE that regulates the synthesis and release of pituitary gonadotropins, LUTEINIZING HORMONE and FOLLICLE STIMULATING HORMONE.

Descriptor ID	D016729
MeSH Number(s)	D06.472.699.327.740.320.400 D12.644.400.400.740.320.400 D12.644.456.460.480 D12.644.548.365.740.320.400 D12.776.631.650.405.740.320.400
Concept/Terms	Leuprolide Leuprolide Leuprorelin Enantone Enantone Leuprolide Acetate Leuprolide Acetate Acetate, Leuprolide Leuprolide Monoacetate Leuprolide Monoacetate Monoacetate, Leuprolide Leuprolide, (L-Leu)-Isomer Leuprolide, (L-Leu)-Isomer Lupron Lupron TAP-144 TAP-144 TAP 144 TAP144 A-43818 A-43818 A 43818 A43818 Leuprolide, (DL-Leu)-Isomer Leuprolide, (DL-Leu)-Isomer

Below are MeSH descriptors whose meaning is more general than "Leuprolide".

Chemicals and Drugs [D]
Hormones, Hormone Substitutes, and Hormone Antagonists [D06]
Hormones [D06.472]
Peptide Hormones [D06.472.699]
Hypothalamic Hormones [D06.472.699.327]
Pituitary Hormone-Releasing Hormones [D06.472.699.327.740]
Gonadotropin-Releasing Hormone [D06.472.699.327.740.320]
Leuprolide [D06.472.699.327.740.320.400]
Amino Acids, Peptides, and Proteins [D12]
Peptides [D12.644]
Neuropeptides [D12.644.400]
Hypothalamic Hormones [D12.644.400.400]
Pituitary Hormone-Releasing Hormones [D12.644.400.400.740]
Gonadotropin-Releasing Hormone [D12.644.400.400.740.320]
Leuprolide [D12.644.400.400.740.320.400]
Oligopeptides [D12.644.456]
Gonadotropin-Releasing Hormone [D12.644.456.460]
Leuprolide [D12.644.456.460.480]
Peptide Hormones [D12.644.548]
Hypothalamic Hormones [D12.644.548.365]
Pituitary Hormone-Releasing Hormones [D12.644.548.365.740]
Gonadotropin-Releasing Hormone [D12.644.548.365.740.320]
Leuprolide [D12.644.548.365.740.320.400]
Proteins [D12.776]
Nerve Tissue Proteins [D12.776.631]
Neuropeptides [D12.776.631.650]
Hypothalamic Hormones [D12.776.631.650.405]
Pituitary Hormone-Releasing Hormones [D12.776.631.650.405.740]
Gonadotropin-Releasing Hormone [D12.776.631.650.405.740.320]
Leuprolide [D12.776.631.650.405.740.320.400]

Below are MeSH descriptors whose meaning is related to "Leuprolide".

Below are MeSH descriptors whose meaning is more specific than "Leuprolide".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Leuprolide" by people in this website by year, and whether "Leuprolide" was a major or minor topic of these publications.

Bar chart showing 11 publications over 11 distinct years, with a maximum of 1 publications in 1996 and 2004 and 2007 and 2008 and 2009 and 2010 and 2011 and 2013 and 2015 and 2016 and 2018

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
2004	0	1	1
2007	1	0	1
2008	1	0	1
2009	0	1	1
2010	0	1	1
2011	0	1	1
2013	0	1	1
2015	0	1	1
2016	0	1	1
2018	1	0	1

Below are the most recent publications written about "Leuprolide" by people in Profiles.

Roach M, Moughan J, Lawton CAF, Dicker AP, Zeitzer KL, Gore EM, Kwok Y, Seider MJ, Hsu IC, Hartford AC, Horwitz EM, Yamoah K, Jones CU, Michalski JM, Lee WR, Pisansky TM, Rabinovitch R, Rotman M, Pryzant RM, Kim HE, Thomas CR, Shipley WU, Sandler HM. Sequence of hormonal therapy and radiotherapy field size in unfavourable, localised prostate cancer (NRG/RTOG 9413): long-term results of a randomised, phase 3 trial. Lancet Oncol. 2018 11; 19(11):1504-1515.

View in: PubMed
Joffe H, Crawford SL, Freeman MP, White DP, Bianchi MT, Kim S, Economou N, Camuso J, Hall JE, Cohen LS. Independent Contributions of Nocturnal Hot Flashes and Sleep Disturbance to Depression in Estrogen-Deprived Women. J Clin Endocrinol Metab. 2016 10; 101(10):3847-3855.

View in: PubMed
Nguyen PL, Jarolim P, Basaria S, Zuflacht JP, Milian J, Kadivar S, Graham PL, Hyatt A, Kantoff PW, Beckman JA. Androgen deprivation therapy reversibly increases endothelium-dependent vasodilation in men with prostate cancer. J Am Heart Assoc. 2015 Apr 20; 4(4).

View in: PubMed
Joffe H, Crawford S, Economou N, Kim S, Regan S, Hall JE, White D. A gonadotropin-releasing hormone agonist model demonstrates that nocturnal hot flashes interrupt objective sleep. Sleep. 2013 Dec 01; 36(12):1977-85.

View in: PubMed
King HM, Kurdziel LB, Meyer JS, Lacreuse A. Effects of testosterone on attention and memory for emotional stimuli in male rhesus monkeys. Psychoneuroendocrinology. 2012 Mar; 37(3):396-409.

View in: PubMed
Lacreuse A, King HM, Kurdziel LB, Partan SR, Caldwell KM, Chiavetta MR, Millette MM, Meyer JS, Grow DR. Testosterone may increase selective attention to threat in young male macaques. Horm Behav. 2010 Nov; 58(5):854-63.

View in: PubMed
Lacreuse A, Chiavetta MR, Shirai AA, Meyer JS, Grow DR. Effects of testosterone on cognition in young adult male rhesus monkeys. Physiol Behav. 2009 Dec 07; 98(5):524-31.

View in: PubMed
Coddington CC, Grow DR, Ahmed MS, Toner JP, Cook E, Diamond MP. Gonadotropin-releasing hormone agonist pretreatment did not decrease postoperative adhesion formation after abdominal myomectomy in a randomized control trial. Fertil Steril. 2009 May; 91(5):1909-13.

View in: PubMed
Levens ED, Whitcomb BW, Kort JD, Materia-Hoover D, Larsen FW. Microdose follicular flare: a viable alternative for normal-responding patients undergoing in vitro fertilization? Fertil Steril. 2009 Jan; 91(1):110-4.

View in: PubMed
Cooper BC, Sites CK, Casson PR, Toth MJ. Ovarian suppression with a gonadotropin-releasing hormone agonist does not alter insulin-stimulated glucose disposal. Fertil Steril. 2007 May; 87(5):1131-8.

View in: PubMed

People

Explore

Similar Concepts

Top Journals